Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP).
about
Contemporary management of primary immune thrombocytopenia in adultsIntracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases.A retrospective analysis of therapeutic responses to two distinct corticosteroids in 259 children with acute primary idiopathic thrombocytopenic purpura.Long-term management of chronic immune thrombocytopenic purpura in adults.Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters.Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia.Management of immune thrombocytopenic purpura in children: potential role of novel agents.Therapeutic options for immune-mediated thrombocytopenia.Use of romiplostim for primary immune thrombocytopenia in children.Eltrombopag, a thrombopoietin- receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile.Refractory immune thrombocytopenia successfully treated with high-dose vitamin D supplementation and hydroxychloroquine: two case reportsRomiplostim in children with chronic immune thrombocytopenia (ITP): the French experience.Diagnosis and management of autoimmune cytopenias in childhood.Absolute lymphocyte count and risk of short-term infection in patients with immune thrombocytopenia.ITP-QoL questionnaire for children with immune thrombocytopenia: Italian version validation's.Vincristine efficacy and safety in treating immune thrombocytopenia: a retrospective study of 35 patients.Treatment of refractory ITP and Evans syndrome by haematopoietic cell transplantation: is it indicated, and for whom?Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and EltrombopagIndirubin Increases CD4+CD25+Foxp3+ Regulatory T Cells to Prevent Immune Thrombocytopenia in Mice.Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years.Clinical Features and Treatment Outcomes of Primary Immune Thrombocytopenic Purpura in Hospitalized Children Under 2-Years Old.Combination therapy in relapsed or refractory chronic immune thrombocytopenia: a case report and literature review.Systemic Inflammatory Response and Severe Thrombocytopenia after Endovascular Thoracic Aortic Aneurysm Repair.State of the art - how I manage immune thrombocytopenia.Spotlight on romiplostim in the treatment of children with chronic immune thrombocytopenia: design, development, and potential place in therapy.Immune Gamma Globulin Therapeutic Indications in Immune Deficiency and Autoimmunity.Intravenous immunoglobulin: a biological corticosteroid-sparing agent in some autoimmune conditions.Management of immune thrombocytopenia: Korean experts recommendation in 2017.Fostamatinib for the Treatment of Adult Persistent and Chronic Immune Thrombocytopenia: Results of Two Phase 3, Randomized, Placebo-Controlled Trials.The Role of Hydroxychloroquine as a Steroid-sparing Agent in the Treatment of Immune Thrombocytopenia: A Review of the Literature.
P2860
Q26853680-0B61FB89-7A6D-4577-B617-3AE11D484962Q33386303-C5280463-4391-4068-A614-0D747CE49B9FQ33386717-A00A5CA5-61A6-49D5-A528-61D77CEC0D48Q33392610-34F8847C-DAD0-4BFC-A69A-05B3A2FD6E18Q33392868-9C431464-6EF2-40F7-9B6C-94253428F88BQ33394438-486F8AA4-4827-4218-A05C-7041228F5FCCQ33395863-8B43B25E-8E1A-40BE-A1F3-C4A4E02596F2Q33399601-9FD33159-0D10-4E48-891E-47115146239FQ33399983-183DCF62-40E5-4FDD-82DE-89DF8E3D664BQ33406838-A77F6505-3588-4475-9A61-1564FD295C7FQ33406845-EC504BCA-7CB0-4332-8719-56DF84A9C43EQ33411082-CD0E7EF7-D89B-4AC8-BD1F-D7AA9B08D05DQ33411497-6C9E7034-7F8B-4942-89C7-421C4B5233A4Q33412766-2243FFAF-3BEF-40AE-A0C5-7F0189924CC9Q33415460-06CF4129-8231-4A41-A89F-D47D5EEA3EBBQ33422846-63D84A50-E183-4D1C-B38C-A87B11031C69Q33424451-88349498-DE22-4E10-8AEA-99285D8D4254Q33424486-17E64711-1F78-4B73-B1BD-0A45D1981153Q33427555-9207C47D-7664-46FA-B2C1-7B2CF642731CQ33429426-4D8F896A-218F-45F3-B9C7-A7736F3AB2CCQ33432482-B8C5086E-6BDB-4C63-9731-1F4ABF1F32AFQ33433705-D7376D88-AA98-4EF9-9513-3EF7F9AAF772Q33438952-E936E92F-E1A4-4317-942F-E05699702586Q33440145-ED67B73B-2272-4014-9344-BC1145880F43Q33440990-B1EDBEDC-121A-4DBE-BADC-D8DF2920AFD3Q38842992-57EB1840-2129-4D78-8D58-55CD7B73DB2FQ39248920-7B2F18A9-0371-4779-B011-E9493BEDCF54Q49624514-1FEEDE17-41FC-49CA-888D-4C94FA588FD5Q52562217-9CB85DA5-EC58-4C1C-83FC-B08A9B666A33Q55129731-A99ED7FC-5D1A-42DF-8ABC-1899867C2EA1
P2860
Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP).
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Multiagent induction and maint ...... hrombocytopenic purpura (ITP).
@ast
Multiagent induction and maint ...... hrombocytopenic purpura (ITP).
@en
type
label
Multiagent induction and maint ...... hrombocytopenic purpura (ITP).
@ast
Multiagent induction and maint ...... hrombocytopenic purpura (ITP).
@en
prefLabel
Multiagent induction and maint ...... hrombocytopenic purpura (ITP).
@ast
Multiagent induction and maint ...... hrombocytopenic purpura (ITP).
@en
P2093
P1433
P1476
Multiagent induction and maint ...... hrombocytopenic purpura (ITP).
@en
P2093
Donna M Boruchov
M Catherine Driscoll
Sri Gururangan
P304
P356
10.1182/BLOOD-2007-01-065763
P407
P577
2007-08-13T00:00:00Z